Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO2 | P16083 | 1/20 | 0.52 |
| ▸ | TRPM4 | Q8TD43 | 1/20 | 0.48 |
| ▸ | IDO1 | P14902 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.38 |
| ▸ | ESR1 | P03372 | 2/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.38 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.38 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.38 |
| ▸ | EP300 | Q09472 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11214170 | 0.86 | GAA (0.51) | TRPM4IDO1CYP1A2ALOX5GAA | |
| SCHEMBL7536353 | 0.82 | POLB (0.44) | NQO2 | |
| SCHEMBL11078909 | 0.78 | IDO1 (0.54) | IDO1ESR1ESR2GAAEP300 | |
| SCHEMBL1581774 | 0.78 | IDO1 (0.65) | IDO1CYP1A2ESR1ESR2GAA | |
| SCHEMBL16346480 | 0.76 | NQO2 (0.87) | NQO2TRPM4IDO1CYP1A2ALOX5 | |
| SCHEMBL14243918 | 0.75 | CYP1A2 (0.55) | NQO2TRPM4CYP1A2ESR1ESR2 | |
| SCHEMBL4339749 | 0.75 | CYP1A2 (0.54) | IDO1CYP1A2ESR1ESR2PTGS1 | |
| SCHEMBL13899985 | 0.75 | IDO1 (0.45) | IDO1GAA | |
| SCHEMBL21554197 | 0.74 | PTPN22 (0.55) | NQO2TRPM4CYP1A2GAARCE1 | |
| SCHEMBL911036 | 0.73 | NQO2 (0.61) | NQO2TRPM4CYP1A2EP300 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020094993-A1 | Compositions for repelling crawling insects | S.C. JOHNSON & SON, INC. | 2002-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020094993-A1 | Compositions for repelling crawling insects | ACHE, DDT, GAP43 | NQO2 4389/4885TRPM4 1666/4885IDO1 2046/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.